文献速递冠心病

药物涂层球囊治疗新发冠状动脉病变:JACC 最新综述

Drug-Coated Balloon for De Novo Coronary Artery Disease: JACC State-of-the-Art Review.
PubMed 文献 · J Am Coll Cardiol · 2020-01-01

本综述聚焦药物涂层球囊(DCB)治疗新发冠状动脉病变的随机试验证据。DCB 在支架内再狭窄中已证实有效,新发病变研究结果不一,小血管病变获益明显;结果差异与 DCB 技术、操作策略及血管大小有关。综述提出未来临床试验设计方向。

要点

  • DCB 治疗新发冠脉病变的随机试验结果不一,小血管病变获益明显。
  • 结果差异与 DCB 技术、操作策略(「不留置」或「联合治疗」)及血管大小有关。
  • 综述基于现有随机试验证据提出未来临床试验设计方向。

核心结论

  • DCB 在新发冠脉病变中的研究结果不一,小血管病变获益明显。
  • 研究结果差异与 DCB 技术、操作策略及血管大小有关。

研究设计与样本

  • 综述纳入 DCB 治疗新发冠状动脉病变的随机试验证据。
  • DCB 由半顺应性球囊及聚合物基质包裹的抗增殖药物涂层构成,扩张接触内膜后药物释放至血管壁。

主要发现

  • DCB 在支架内再狭窄中已证实有效。
  • DCB 治疗新发冠脉病变的临床研究结果不一,小血管病变获益明显。
  • 结果差异与 DCB 技术差异、操作策略(「不留置」或「联合治疗」)及血管大小不同有关。

关键数值与推荐

  • 药物洗脱支架经皮冠状动脉介入仍是冠脉血运重建最常见方式,但再狭窄率仍高。

临床怎么用

  • DCB 作为无金属网格的局部药物递送方式,可用于支架内再狭窄治疗。
  • 新发冠脉病变应用 DCB 需考虑 DCB 技术、操作策略及血管大小对结果的影响。

局限性

  • 新发冠脉病变的 DCB 临床研究结果不一,证据尚不统一。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Percutaneous coronary intervention with a drug-eluting stent is the most common mode of revascularization for coronary artery disease. However, restenosis rates remain high. Non-stent-based local drug delivery by a drug-coated balloon (DCB) has been investigated, as it leaves no metallic mesh. A DCB consists of a semicompliant balloon coated with antiproliferative agents encapsulated in a polymer matrix, which is released into the wall after inflation and contact with the intima. DCB have demonstrated effectiveness in treating in-stent restenosis. Clinical studies using DCB in de novo coronary artery disease have shown mixed results, with a major benefit in small-vessel disease. Differences in study results are not only due to variations in DCB technology but also to disparity in procedural approach, "leave nothing behind" or "combination therapy," and vessel size. This review focuses on the available evidence from randomized trials and proposes a design for future clinical trials.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Yerasi C, Case BC, Forrestal BJ, et al. Drug-Coated Balloon for De Novo Coronary Artery Disease: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020. PMID: 32138967. doi:10.1016/j.jacc.2019.12.046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。